FTC extends comment period
This article was originally published in The Tan Sheet
Executive Summary
FTC grants a 90-day extension of the March 19 deadline for comments related to the commission's Guides Concerning the Use of Endorsements and Testimonials in Advertising and two consumer surveys it commissioned. The Electronic Retailing Association said it needs more time to evaluate the two reports and compile member opinions on the subject, FTC states. The new deadline for comments is June 18, according to FTC. The commission published the results of the two commissioned studies on efficacy of testimonial ads' disclosure statements in January. The studies found dietary supplements' disclosure statements are largely ineffective in helping consumers understand efficacy claims communicated in a testimonial advertisement (1"The Tan Sheet" Jan. 22, 2007, p. 10)....
You may also be interested in...
Disclosure Statements In Testimonial Ads Largely Ineffective – FTC Studies
Results from two studies funded by the Federal Trade Commission show disclosure statements for dietary supplements are largely ineffective in helping consumers understand product efficacy claims after they view testimonial advertisements
First Drugs That Could Be Picked For Price Negotiation Showcase Longevity Of Some Brands
The first drugs expected to face US Medicare drug price negotiations, according to a new analysis, will have had an average commercial life span of 15 years.
ThirtyFiveBio Makes Its Debut With First-In-Class GPR35 Antagonist Approach
Emerging Company Profile: Backed by $20m in seed funding, the UK firm is going against the grain by antagonizing, instead of agonizing, G protein-coupled receptor 35 with an eye to treating colorectal cancer and other gastrointestinal conditions.